NorthRock Partners’s GSK GSK Stock Holding History

NorthRock Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,046	Closed	-$275K	–	325
2022 Q1	$275K	Sell	5,046 -1,116	-18%	-$60.6K	0.02%	255
2021 Q4	$340K	Buy	+6,162	New	+$321K	0.03%	221
2021 Q3	–	Sell	-4,031	Closed	-$201K	–	286
2021 Q2	$201K	Buy	+4,031	New	+$194K	0.02%	243
2020 Q1	–	Sell	-13,382	Closed	-$786K	–	239
2019 Q4	$786K	Buy	+13,382	New	+$744K	0.08%	117
2019 Q2	–	Sell	-4,101	Closed	-$217K	–	84
2019 Q1	$217K	Buy	+4,101	New	+$205K	0.06%	79

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

NorthRock Partners's GSK Position: Q2 2022 in Review

NorthRock Partners sold out of GSK (GSK) in Q2 2022, closing a stake of 5,046 shares — an estimated $275K sold.

NorthRock Partners first reported a position in GSK in Q1 2019 and held it in 5 quarters. The position peaked at $786K in Q4 2019. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

NorthRock Partners reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
NorthRock Partners sold 5,046 GSK shares in Q2 2022, an estimated $275K.
NorthRock Partners first reported a position in GSK in Q1 2019 and held it in 5 quarters.
NorthRock Partners's GSK position peaked at $786K in Q4 2019.
900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on NorthRock Partners's 13F filing for Q2 2022, filed 4 Aug 2022.